Mary Beth DeYoung

1.6k total citations
23 papers, 1.4k citations indexed

About

Mary Beth DeYoung is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Mary Beth DeYoung has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Mary Beth DeYoung's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Protease and Inhibitor Mechanisms (6 papers). Mary Beth DeYoung is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Protease and Inhibitor Mechanisms (6 papers). Mary Beth DeYoung collaborates with scholars based in United States and Ireland. Mary Beth DeYoung's co-authors include David A. Dichek, David G. Parkes, Catherine Lowe, Robert M. Graham, Dianne M. Perez, Michael Trautmann, Leigh MacConell, Paul Herbert, Vanita R. Aroda and Jenny Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mary Beth DeYoung

22 papers receiving 1.3k citations

Peers

Mary Beth DeYoung
Yumi Takiyama Japan
Zhi‐Ming Ding United States
Laura J. Bloem United States
Martin Hennenberg Germany
Tsugumichi Saito Japan
Helén L. Dichek United States
Russell J. Wiese United States
Akio Kawakami Japan
Sara S. Roscioni Netherlands
Kathrin Weyer Denmark
Yumi Takiyama Japan
Mary Beth DeYoung
Citations per year, relative to Mary Beth DeYoung Mary Beth DeYoung (= 1×) peers Yumi Takiyama

Countries citing papers authored by Mary Beth DeYoung

Since Specialization
Citations

This map shows the geographic impact of Mary Beth DeYoung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beth DeYoung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beth DeYoung more than expected).

Fields of papers citing papers by Mary Beth DeYoung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Beth DeYoung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beth DeYoung. The network helps show where Mary Beth DeYoung may publish in the future.

Co-authorship network of co-authors of Mary Beth DeYoung

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Beth DeYoung. A scholar is included among the top collaborators of Mary Beth DeYoung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Beth DeYoung. Mary Beth DeYoung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meloni, Alison R., Mary Beth DeYoung, Jenny Han, Jennie H. Best, & Michael Grimm. (2013). Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals. Cardiovascular Diabetology. 12(1). 48–48. 17 indexed citations
2.
DeYoung, Mary Beth, et al.. (2012). GLP ‐1 receptor activated insulin secretion from pancreatic β‐cells: mechanism and glucose dependence. Diabetes Obesity and Metabolism. 15(1). 15–27. 292 indexed citations
3.
Aroda, Vanita R., Robert R. Henry, Jenny Han, et al.. (2012). Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review. Clinical Therapeutics. 34(6). 1247–1258.e22. 204 indexed citations
4.
5.
DeYoung, Mary Beth, et al.. (2011). Encapsulation of Exenatide in Poly-( d,l -Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes. Diabetes Technology & Therapeutics. 13(11). 1145–1154. 204 indexed citations
6.
Aroda, Vanita R. & Mary Beth DeYoung. (2011). Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes. Postgraduate Medicine. 123(5). 228–238. 22 indexed citations
7.
8.
9.
10.
Cozen, Aaron E., Hideaki Moriwaki, Mary Beth DeYoung, et al.. (2004). Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death. Circulation. 109(17). 2129–2135. 77 indexed citations
11.
DeYoung, Mary Beth, Andrew Siwkowski, & Arnold Hampel. (2003). Determination of Catalytic Parameters for Hairpin Ribozymes. PubMed. 74. 209–220. 9 indexed citations
12.
Siwkowski, Andrew, et al.. (2003). Mutagenesis and Modeling of the Hairpin Ribozyme Family. Humana Press eBooks. 74. 357–364. 4 indexed citations
13.
DeYoung, Mary Beth, et al.. (2001). Plasminogen Activator Inhibitor Type 1 Increases Neointima Formation in Balloon-Injured Rat Carotid Arteries. Circulation. 104(16). 1972–1971. 70 indexed citations
14.
Schneider, Darren B., Giuseppe Vassalli, Shan Wen, et al.. (2000). Expression of Fas Ligand in Arteries of Hypercholesterolemic Rabbits Accelerates Atherosclerotic Lesion Formation. Arteriosclerosis Thrombosis and Vascular Biology. 20(2). 298–308. 68 indexed citations
15.
DeYoung, Mary Beth, et al.. (1999). Optimizing Vascular Gene Transfer of Plasminogen Activator Inhibitor 1. Human Gene Therapy. 10(9). 1469–1478. 16 indexed citations
16.
DeYoung, Mary Beth & David A. Dichek. (1998). Gene Therapy for Restenosis. Circulation Research. 82(3). 306–313. 57 indexed citations
17.
Siwkowski, Andrew, et al.. (1998). Screening for Important Base Identities in the Hairpin Ribozyme by In Vitro Selection for Cleavage. BioTechniques. 24(2). 278–284. 15 indexed citations
18.
Dong, Gang, Andrew H. Schulick, Mary Beth DeYoung, & David A. Dichek. (1996). Identification of a cis-Acting Sequence in the Human Plasminogen Activator Inhibitor Type-1 Gene That Mediates Transforming Growth Factor-β1 Responsiveness in Endothelium in Vivo. Journal of Biological Chemistry. 271(47). 29969–29977. 38 indexed citations
19.
DeYoung, Mary Beth, Andrew Siwkowski, Ying Lian, & Arnold Hampel. (1995). Catalytic Properties of Hairpin Ribozymes Derived from Chicory Yellow Mottle Virus and Arabis Mosaic Virus Satellite RNAs. Biochemistry. 34(48). 15785–15791. 33 indexed citations
20.
Perez, Dianne M., Mary Beth DeYoung, & Robert M. Graham. (1993). Coupling of expressed alpha 1B- and alpha 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific.. Molecular Pharmacology. 44(4). 784–795. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yumi Takiyama Breakdown of academic impact, for papers by Zhi‐Ming Ding Breakdown of academic impact, for papers by Laura J. Bloem Breakdown of academic impact, for papers by Martin Hennenberg Breakdown of academic impact, for papers by Tsugumichi Saito Breakdown of academic impact, for papers by Helén L. Dichek Breakdown of academic impact, for papers by Russell J. Wiese Breakdown of academic impact, for papers by Akio Kawakami Breakdown of academic impact, for papers by Sara S. Roscioni Breakdown of academic impact, for papers by Kathrin Weyer
Rankless by CCL
2026